Depression is not a mood.
It's a medical condition — and it's treatable.
Major Depressive Disorder is one of the most common and most burdensome conditions in medicine. It changes how you think, feel, sleep, eat, and experience the world. It also responds, often dramatically, to the right treatment — and you don't have to figure out what that is alone.
What Is Major Depressive Disorder?
Major Depressive Disorder (MDD) is a clinical diagnosis characterized by one or more major depressive episodes — periods of at least two weeks in which a person experiences a persistent depressed mood or a loss of interest in almost all activities, along with a cluster of other symptoms that significantly impair functioning.
MDD is not sadness in response to difficult circumstances. It is not a character flaw, a sign of weakness, or a failure to be grateful for what you have. It is a medical condition with measurable neurobiological correlates — changes in brain chemistry, structure, and function — that requires treatment just as any other medical condition does.
"Depression lies. It tells you that nothing will help, that you don't deserve to feel better, that this is just who you are. None of that is true — and that's exactly why treatment matters."
More Than Feeling Low
One of the most persistent barriers to seeking treatment for depression is the belief that what someone is experiencing isn't "bad enough" — that real depression looks a certain way, and ordinary sadness or emptiness doesn't qualify. This belief is both common and harmful.
Major depressive episodes don't always involve dramatic suffering. They can look like numbness, emptiness, or a gradual withdrawal from life. They can be masked by busyness, achievement, or a managed exterior that hides profound internal suffering. They can last for years in the background before anyone — including the person experiencing them — recognizes what's happening.
If you've been struggling with persistent low mood, loss of pleasure, fatigue, or a sense that life has dimmed — and it's been going on for weeks or months — that is worth evaluating. You don't have to wait until things get worse.
Depression Is More Than Feeling Sad
Major depressive episodes affect every domain of experience — emotional, physical, cognitive, and behavioral. Many people with depression don't primarily feel sad at all.
Persistent Low or Empty Mood
A pervasive sense of sadness, emptiness, or hopelessness that is present most of the day, nearly every day. This is distinct from normal sadness — it is less responsive to circumstances, less connected to specific events, and more enduring.
Loss of Pleasure — Anhedonia
Markedly diminished interest or pleasure in activities that were previously enjoyable — hobbies, socializing, food, sex, creative work. Anhedonia is one of the most diagnostically significant and functionally disabling symptoms of MDD, and is often more prominent than sadness.
Fatigue & Loss of Energy
Profound, persistent fatigue that is not relieved by rest. Even small tasks feel disproportionately effortful. This is not laziness — it is a genuine neurobiological symptom that reflects the metabolic cost depression places on the brain and body.
Cognitive Impairment
Difficulty concentrating, remembering, or making decisions. A slowing of thought that can feel like a fog or a dimming of mental clarity. In older adults, cognitive symptoms of depression can be mistaken for early dementia — another reason accurate diagnosis matters.
Sleep Disruption
Insomnia — difficulty falling or staying asleep, or early morning awakening with inability to return to sleep — is extremely common in depression. So is hypersomnia: sleeping far more than usual without feeling rested. Both patterns reflect the same underlying disruption to sleep architecture.
Changes in Appetite & Weight
Significant decrease or increase in appetite — and corresponding weight changes — not attributable to dieting or other causes. Some people lose all interest in food; others eat compulsively as a way of managing distress.
Worthlessness & Excessive Guilt
Persistent feelings of worthlessness, self-blame, or excessive or inappropriate guilt — not simply regret about specific circumstances, but a global sense of inadequacy or fault that depression generates independent of actual events.
Physical Symptoms
Headaches, digestive problems, chronic pain, and other physical symptoms that don't have clear medical explanation are common in depression. The brain and body are not separate systems — depression is a whole-body condition.
Thoughts of Death or Suicide
Recurrent thoughts of death, passive wishes not to be alive, or active suicidal ideation. These thoughts are a symptom of the illness — not a moral failing, a decision, or a sign of who you are. They require attention and care, and effective treatment dramatically reduces their intensity and frequency.
Subtypes & Specifiers of MDD
The DSM-5 recognizes several clinically important subtypes and specifiers of Major Depressive Disorder. Accurate identification shapes treatment selection — which is why a thorough evaluation matters.
With Anxious Distress
The most common specifier — co-occurring anxiety symptoms including tension, restlessness, difficulty concentrating due to worry, and fear of losing control. Depression with anxious distress often requires a somewhat different treatment approach than depression without it.
With Melancholic Features
Profound anhedonia that extends even to anticipated positive events, distinct quality of depressed mood that is different from ordinary sadness, early morning awakening, and psychomotor changes. Melancholic depression often responds better to certain medication classes.
With Atypical Features
Mood reactivity (able to brighten briefly in response to positive events), significant weight gain or appetite increase, hypersomnia, leaden paralysis, and a longstanding pattern of interpersonal rejection sensitivity. Atypical depression is more common than many people realize.
With Psychotic Features
The presence of delusions or hallucinations alongside the depressive episode — often with mood-congruent content (themes of guilt, punishment, disease, or nihilism). Psychotic depression requires specific medication management and close monitoring.
With Peripartum Onset
Major depressive episodes that begin during pregnancy or in the four weeks following delivery. Postpartum depression affects approximately 1 in 5 new mothers and is significantly undertreated — partly due to stigma and the cultural expectation of joy following birth.
With Seasonal Pattern
Major depressive episodes that reliably occur at a particular time of year — most commonly fall and winter — with full remission in other seasons. Seasonal affective disorder (SAD) involves the same neurobiological mechanisms as non-seasonal MDD, with the addition of circadian and light-related factors.
MDD Treatment at NBCG
Effective depression treatment is rarely one thing. NBCG offers the full spectrum — from evidence-based psychotherapy to medication management to advanced interventional options for depression that hasn't responded to standard approaches.
Cognitive Behavioral Therapy (CBT)
CBT is the most well-researched psychotherapy for depression and produces durable outcomes — meaning the gains often persist after treatment ends, better than medication alone. It addresses the thought patterns and behavioral cycles that maintain depression, and builds practical skills for managing low mood, low motivation, and negative self-perception.
Behavioral Activation
One of the most evidence-supported components of depression treatment — restoring engagement with meaningful, rewarding activities to break the withdrawal-isolation cycle that perpetuates depression. Sometimes the most powerful intervention is also the most concrete: doing, not just thinking differently.
Interpersonal Therapy (IPT)
IPT focuses on the relationship between depression and interpersonal functioning — grief, role transitions, relationship conflicts, and social isolation. It is highly effective for MDD and particularly well-suited to depression that is clearly tied to relationship or life circumstances.
Antidepressant Medication
SSRIs, SNRIs, and other antidepressant classes are first-line medical treatments for moderate to severe MDD and can significantly reduce symptom severity, often within four to six weeks. Medication selection is individualized — based on your symptom profile, history, tolerability preferences, and other medications — and managed collaboratively with your provider.
Transcranial Magnetic Stimulation (TMS)
TMS is an FDA-cleared, non-invasive treatment for MDD that uses targeted magnetic pulses to stimulate the areas of the brain associated with mood regulation. It is particularly effective for treatment-resistant depression — and unlike ECT, requires no anesthesia, no sedation, and has minimal side effects. Available at select NBCG locations.
Ketamine & Spravato (Esketamine)
For treatment-resistant depression, ketamine infusions and Spravato (FDA-approved intranasal esketamine) can produce rapid, significant antidepressant effects — sometimes within hours of the first treatment. These options offer meaningful hope for people who have not responded to multiple prior treatments. Available at select NBCG locations.
Treatment-Resistant Depression
Treatment-resistant depression (TRD) is generally defined as depression that has not responded adequately to at least two different antidepressant treatments given at adequate doses and duration. It affects roughly one in three people with MDD — meaning millions of people are living with depression that hasn't yet found its answer.
TRD is not a dead end. It is a diagnostic signal — an indication that the treatment approach needs to be expanded, refined, or fundamentally reconsidered. NBCG's capacity for advanced interventional treatments means that people who have exhausted standard options have meaningful alternatives available.
If you've tried antidepressants and therapy without adequate results, please don't conclude that nothing will work. The story isn't finished — there are options you may not have tried, and providers trained specifically in navigating complex, treatment-resistant presentations.
Medication Optimization & Augmentation
Before pursuing advanced interventions, a thorough review of medication history — doses, duration, combinations, and tolerability — often reveals opportunities. Augmentation strategies (adding lithium, atypical antipsychotics, or thyroid supplementation) have strong evidence for TRD.
Transcranial Magnetic Stimulation (TMS)
TMS has FDA clearance specifically for treatment-resistant depression and produces response rates of 50–60% in people who have not responded to medication. It is non-invasive, performed outpatient, and well-tolerated.
Ketamine & Spravato
Both IV ketamine and Spravato have demonstrated rapid antidepressant effects in TRD, sometimes producing meaningful improvement within hours. Spravato is FDA-approved for TRD and for MDD with acute suicidal ideation — a unique and important distinction.
Psychotherapy for TRD
When medication alone hasn't worked, adding or changing psychotherapy is often productive. Approaches including CBT, Behavioral Activation, and CBASP (Cognitive Behavioral Analysis System of Psychotherapy, developed specifically for chronic depression) can reach what medication doesn't.
The NBCG Difference
Most outpatient mental health practices offer therapy, and some offer medication management. NBCG offers the full spectrum — from first-line evidence-based psychotherapy through advanced interventional treatments for the depression that hasn't responded to anything else. Wherever you are on that spectrum, we have something to offer.
We accept most major insurance plans, including SelectHealth, BCBS, Regence, Aetna, Cigna, UnitedHealthcare, and more. Our team can help verify your benefits — including coverage for TMS and Spravato — before your first appointment.
Depression tells you nothing will help.
Depression is wrong.
One of the most important things to know about Major Depressive Disorder is that the hopelessness it generates is a symptom — not a forecast. Most people who receive appropriate treatment experience real, meaningful improvement. Many experience full remission. You don't have to take the illness's word for it.
Our intake process is straightforward and confidential. Same-week appointments are often available — and we'll meet you wherever you are.
Utah Locations
Six convenient locations across the Wasatch Front.
Logan, UT 84321
- ABA & Autism Services
- Speech Therapy
5974 S. Fashion Pointe Drive, Suite 140
South Ogden, UT 84403
- ABA & Autism Services
- Thrive Learning Center
- Speech Therapy
5926 S. Fashion Pointe Drive, Suite 120
South Ogden, UT 84403
- Psych & Neuropsych Testing
- Mental Health Therapy
- Psychiatric Med Management
- TMS, Spravato, & Ketamine
Layton, UT 84041
- Mental Health Therapy
415 S Medical Drive, #B102
Bountiful, UT 84010
- Psychiatric Med Management
- TMS, Spravato, & Ketamine
415 S Medical Drive, #A100
Bountiful, UT 84010
- Psych & Neuropsych Testing
- Mental Health Therapy
- ABA & Autism Services
- Speech Therapy
370 E South Temple Street, #125
Salt Lake City, UT 84111
- Psychiatric Med Management
- TMS, Spravato, & Ketamine
370 E South Temple Street, #175
Salt Lake City, UT 84111
- Psych & Neuropsych Testing
- Mental Health Therapy
West Jordan, UT 84084
- ABA & Autism Services
- Psych & Neuropsych Testing
- Mental Health Therapy
- Psychiatric Med Management
You've been carrying this
long enough.
Whether this is your first depressive episode or your fifth, whether you're looking for a first opinion or a second one, whether you've never tried treatment or tried many things that didn't work — there are options. And we're here to help you find yours.
Indications for Treatment
The providers at Neurobehavioral Center for Growth (NBCG) offer psychiatric evaluation and treatment in Utah for Major Depressive Disorder (MDD) and related conditions including treatment-resistant depression, persistent depressive disorder (dysthymia), seasonal affective disorder, postpartum depression, and co-occurring conditions including anxiety disorders, PTSD, and substance use disorders. NBCG serves children, adolescents, and adults. Treatment is determined based on individual psychiatric evaluations and may include psychotherapy, medication management, TMS, Spravato, ketamine, and coordinated care planning.
TMS, Spravato & Ketamine — Important Safety Information
Transcranial Magnetic Stimulation (TMS) is FDA-cleared for treatment-resistant major depressive disorder and OCD. Common side effects include scalp discomfort and headache during or after sessions. Serious side effects, including seizure, are rare. TMS is not appropriate for individuals with certain metal implants or a history of seizure disorders.
Spravato (esketamine) is FDA-approved for treatment-resistant depression and for major depressive disorder with acute suicidal ideation. It is administered in a certified healthcare setting with required post-dose monitoring. Common side effects include dissociation, dizziness, nausea, and sedation. Spravato has abuse potential and is available only through a restricted distribution program. Ketamine infusions are used off-label for treatment-resistant depression and are administered in a monitored clinical setting. Side effects include dissociation, elevated blood pressure, and nausea. Both treatments require clinical assessment for eligibility.
Suicidality
Major depressive disorder is associated with elevated rates of suicidal ideation and suicide attempts. Antidepressant medications carry an FDA black-box warning regarding increased risk of suicidal thinking in children, adolescents, and young adults during the early weeks of treatment. Patients and families should monitor for worsening symptoms, agitation, or new suicidal thoughts and contact their provider immediately if these occur. If you or someone you know is in immediate danger, please call or text 988 (Suicide & Crisis Lifeline) or contact emergency services. NBCG provides outpatient mental health care and is not an emergency or crisis service.
